Fundz

ALX Oncology Appoints Allison Dillon, Ph.D., as Chief Business Officer

PUBLIC · ALXOMay 07, 2024

Position

Chief Business Officer

Company

ALX Oncology

Allison Dillon
adillon@alxoncology.com
South San FranciscoBiotechnologyHealth CareMedicalTherapeutics

Description

ALX Oncology Holdings Inc. announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer

Quick answer

ALX Oncology Appoints Allison Dillon, Ph.D., as Chief Business Officer (May 7, 2024). ALX Oncology is based in South San Francisco, California, United States.

Who is the new Chief Business Officer at ALX Oncology?
ALX Oncology named Allison Dillon Chief Business Officer, announced May 7, 2024.
What did ALX Oncology announce on May 7, 2024?
ALX Oncology Holdings Inc. announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer
What does ALX Oncology do?
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.
Where is ALX Oncology based?
ALX Oncology is based in South San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
neurocare (May 7, 2024), Wave Life Sciences (May 9, 2024), Scipher Medicine (May 9, 2024) and Qihan Biotech (May 9, 2024) also announced leadership changes within 45 days of ALX Oncology.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ALX Oncology, and when

A new leader at ALX Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ALX Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ALX Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ALX Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ALX Oncology

Location

South San Francisco, California, United States

About

ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ALX Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Allison
Likely contact at this company
••••••••@••••••••

See Allison's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ALX Oncology's next move

Learn about Strategic plan

ALX Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.